P. S. Stewart and J. W. Costerton, Antibiotic resistance of bacteria in biofilms, Lancet, vol.358, issue.9276, pp.135-138, 2001.

R. M. Donlan and J. W. Costerton, Biofilms: survival mechanisms of clinically relevant microorganisms, Clin Microbiol Rev, vol.15, issue.2, pp.167-93, 2002.

J. E. Michiels, B. Van-den-bergh, N. Verstraeten, M. Fauvart, and J. Michiels, In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens, Antimicrob. Agents Chemother, p.4630, 2016.

C. D. Nadell, K. Drescher, N. S. Wingreen, and B. L. Bassler, Extracellular matrix structure governs invasion resistance in bacterial biofilms, ISME J, vol.9, p.1700, 2015.

H. C. Flemming and J. Wingender, The biofilm matrix, Nat. Rev. Microbiol, vol.2010, issue.9, pp.623-656

S. L. Percival, K. E. Hill, S. Malic, D. W. Thomas, and D. W. Williams, Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound repair and regeneration, vol.19, pp.1-9, 2011.

L. R. Mulcahy, J. L. Burns, S. Lory, and K. Lewis, Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis, J. Bacteriol, issue.23, pp.6191-6200, 2010.

E. Werner, F. Roe, A. Bugnicourt, M. J. Franklin, A. Heydorn et al., Stratified growth in Pseudomonas aeruginosa biofilms, Appl. Environ. Microbiol, vol.70, issue.10, pp.6188-96, 2004.

S. P. Lopes, N. F. Azevedo, and M. O. Pereira, Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions, BioMed Res. Int, p.678301, 2014.

J. W. Costerton, Cystic fibrosis pathogenesis and the role of biofilms in persistent infection, Trends Microbiol, vol.9, issue.2, pp.50-52, 2001.

B. J. Staudinger, J. F. Muller, S. Halldo?sson, B. Boles, A. Angermeyer et al., Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection, Am. J. Respir. Crit. Care Med, vol.189, issue.7, pp.1-58, 2014.

M. M. Mihai, A. M. Holban, C. Giurcaneanu, L. G. Popa, R. M. Oanea et al., Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infections, Curr. Top. Med. Chem, issue.16, pp.1552-76, 2015.

M. Schobert and D. Jahn, Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung, Int. J. Med. Microbiol, issue.8, pp.549-56, 2010.

M. Starkey, J. H. Hickman, L. Ma, N. Zhang, S. De-long et al., Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung, Journal of bacteriology, vol.191, issue.11, pp.3492-3503, 2009.

S. H. Cheng, R. J. Gregory, J. Marshall, S. Paul, D. W. Souza et al., Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis, Cell, vol.63, issue.4, pp.827-834, 1990.

R. B. Fick and . Jr, Pathogenesis of the pseudomonas lung lesion in cystic fibrosis, Chest, vol.96, issue.1, pp.158-64, 1989.

M. J. Cox, M. Allgaier, B. Taylor, M. S. Baek, Y. J. Huang et al., Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients, PLoS One, vol.5, issue.6, p.11044, 2010.

T. Bjarnsholt, P. O. Jensen, M. J. Fiandaca, J. Pedersen, C. R. Hansen et al., Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients, Pediatr Pulmonol, vol.44, issue.6, pp.547-58, 2009.

P. J. Mogayzel, . Jr, E. T. Naureckas, K. A. Robinson, C. Brady et al., Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines, C. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection, Ann. Am. Thorac. Soc, vol.11, issue.10, pp.1640-50, 2014.

B. W. Ramsey, Management of pulmonary disease in patients with cystic fibrosis, N. Engl. J. Med, vol.335, issue.3, pp.179-88, 1996.

A. F. Barker, L. Couch, S. B. Fiel, M. H. Gotfried, J. Ilowite et al., Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis, Am. J. Respir. Crit. Care Med, vol.162, issue.2, pp.481-486, 2000.

T. D. Murphy, R. D. Anbar, L. A. Lester, S. Z. Nasr, B. Nickerson et al., Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease, Pediatr Pulmonol, vol.38, issue.4, pp.314-320, 2004.

W. C. Chiang, M. Nilsson, P. O. Jensen, N. Hoiby, T. E. Nielsen et al., Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms, Antimicrob. Agents Chemother, vol.2013, issue.5, pp.2352-61

R. A. Hatch, N. L. Schiller, W. W. Nichols, S. Dorrington, M. Slack et al., Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa, Antimicrob. Agents Chemother, vol.42, issue.4, pp.518-523, 1988.

B. S. Tseng, W. Zhang, J. J. Harrison, T. P. Quach, J. L. Song et al., The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin, Environ. Microbiol, vol.15, issue.10, pp.2865-2878, 2013.

J. J. Wine, Measuring mucociliary transport and mucus properties in multiple regions of airway epithelial surfaces helps clarify cystic fibrosis defects, Paediatric respiratory reviews, vol.3, issue.2, pp.115-119, 2002.

S. K. Lai, Y. Wang, and J. Hanes, Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues, Adv. Drug Delivery Rev, vol.61, issue.2, pp.158-171, 2009.

P. G. Bhat, D. R. Flanagan, and M. D. Donovan, Drug diffusion through cystic fibrotic mucus: Steady-state permeation, rheologic properties, and glycoprotein morphology, J. Pharm. Sci, vol.85, issue.6, 1996.

J. Du, H. M. Bandara, P. Du, H. Huang, K. Hoang et al., Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa, Biofilms. Mol. Pharmaceutics, vol.12, issue.5, pp.1544-53, 2015.

M. Z. Atassi and T. Manshouri, Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates of peptides, J. Protein Chem, vol.10, issue.6, pp.623-627, 1991.

J. M. Dust, Z. H. Fang, and J. M. Harris, Proton NMR characterization of poly (ethylene glycols) and derivatives. Macromolecules, vol.23, pp.3742-3746, 1990.

M. Roberts and D. F. Scholes, Monofunctional Poly(ethy1ene glycol): Characterization and Purity for Protein-Modification Applications, Chemical Aspects of Drug Delivery Systems

D. R. Karsa, R. A. Sa, and G. T. Hermanson, Zero-Length Crosslinkers, Bioconjugate Techniques, vol.178, 1996.

G. T. Hermanson and . Ed, , pp.215-233, 2008.

E. L. Ferguson, E. Azzopardi, J. L. Roberts, T. R. Walsh, and D. W. Thomas, Dextrin?Colistin Conjugates as a Model Bioresponsive Treatment for Multidrug Resistant Bacterial Infections, Mol. Pharmaceutics, vol.11, issue.12, pp.4437-4447, 2014.

L. Szila?yi, Assignments of the 1H-and 13C-nmr spectra of tobramycin at low and high pH, Carbohydr. Res, vol.170, issue.1, pp.1-17, 1987.

H. M. Bandara, A. Harb, D. Kolacny, . Jr, P. Martins et al., Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro, AAPS PharmSciTech, vol.15, issue.6, pp.1644-54, 2014.

H. M. Bandara, O. L. Lam, R. M. Watt, L. J. Jin, and L. P. Samaranayake, Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species, J. Med. Microbiol, vol.59, pp.1225-1259, 2010.

J. M. Andrews, Determination of minimum inhibitory concentrations, J. Antimicrob. Chemother, vol.48, pp.5-16, 2001.

D. D. Sriramulu, H. Lunsdorf, J. S. Lam, and U. Romling, Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung, J. Med. Microbiol, vol.54, issue.7, pp.667-676, 2005.

K. H. Turner, A. K. Wessel, G. C. Palmer, J. L. Murray, and M. Whiteley, Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum, Proc. Natl. Acad. Sci. U. S. A, vol.112, issue.13, pp.4110-4115, 2015.

C. Fung, S. Naughton, L. Turnbull, P. Tingpej, B. Rose et al., Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum, J. Med. Microbiol, vol.59, issue.9, pp.1089-1100, 2010.

H. Matsui, V. E. Wagner, D. B. Hill, U. E. Schwab, T. D. Rogers et al., A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms, Proc. Natl. Acad. Sci. U. S. A, issue.48, pp.18131-18136, 2006.

T. Brandt, S. Breitenstein, H. Hardt, and B. Tummler, DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase, Thorax, vol.50, issue.8, pp.880-882, 1995.

M. Ghani and J. S. Soothill, Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa, Can. J. Microbiol, vol.43, issue.11, pp.999-1004, 1997.

A. Barth and T. Pitt, The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa, J. Med. Microbiol, vol.45, issue.2, pp.110-119, 1996.

S. S. Yoon, R. Coakley, G. W. Lau, S. V. Lymar, B. Gaston et al., Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions, J. Clin. Invest, vol.116, issue.2, p.436, 2006.

H. Naghili, H. Tajik, K. Mardani, S. M. Razavi-rouhani, A. Ehsani et al., Validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests, Vet Res. Forum, vol.2013, issue.3, pp.179-183

M. Lethem, S. James, C. Marriott, and J. Burke, The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum, Eur. Respir. J, vol.3, issue.1, pp.19-23, 1990.

J. Zahm, S. G. De-bentzmann, E. Deneuville, C. Perrot-minnot, A. Dabadie et al., Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus, Eur. Respir. J, vol.8, issue.3, pp.381-386, 1995.

B. K. Rubin, Mucus structure and properties in cystic fibrosis. Paediatric respiratory reviews, vol.8, pp.4-7, 2007.

P. Russo, M. Stigliani, L. Prota, G. Auriemma, C. Crescenzi et al., Gentamicin and leucine inhalable powder: what about antipseudomonal activity and permeation through cystic fibrosis mucus?, Int. J. Pharm, vol.440, issue.2, pp.250-255, 2013.

J. Leal, H. D. Smyth, and D. Ghosh, Physicochemical properties of mucus and their impact on transmucosal drug delivery, Int. J. Pharm, vol.2017, issue.1, pp.555-572

S. K. Lai, D. E. O'hanlon, S. Harrold, S. T. Man, Y. Wang et al., Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus, Proc. Natl. Acad. Sci. U. S. A, vol.104, issue.5, pp.1482-1487, 2007.

J. S. Suk, S. K. Lai, Y. Wang, L. M. Ensign, P. L. Zeitlin et al., The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles, Biomaterials, vol.30, issue.13, pp.2591-2597, 2009.

J. S. Suk, A. J. Kim, K. Trehan, C. S. Schneider, L. Cebotaru et al., Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier, J. Controlled Release, vol.178, pp.8-17, 2014.

Y. Huang, W. Leobandung, A. Foss, and N. A. Peppas, Molecular aspects of muco-and bioadhesion:: Tethered structures and sitespecific surfaces, J. Controlled Release, vol.65, issue.1, pp.63-71, 2000.

A. Abdi-ali, M. Mohammadi-mehr, and Y. A. Alaei, Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa, Int. J. Antimicrob. Agents, vol.27, issue.3, 2006.

M. Rosenfeld, R. Gibson, S. Mcnamara, J. Emerson, K. S. Mccoy et al., Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis, J. Pediatr, vol.139, issue.4, pp.572-577, 2001.

D. Sehgal and I. K. Vijay, A Method for the High Efficiency of Water-Soluble Carbodiimide-Mediated Amidation, Anal. Biochem, vol.218, issue.1, pp.87-91, 1994.

Z. Grabarek and J. Gergely, Zero-length crosslinking procedure with the use of active esters, Anal. Biochem, vol.185, issue.1, pp.131-135, 1990.

M. A. Gilles, A. Q. Hudson, and C. Borders, Jr Stability of watersoluble carbodiimides in aqueous solution, Anal. Biochem, vol.184, issue.2, pp.244-248, 1990.

M. Brandl and L. Gu, Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media, Drug Dev. Ind. Pharm, vol.18, issue.13, pp.123-130, 1992.

F. Malz and H. Jancke, Validation of quantitative NMR, J. Pharm. Biomed. Anal, vol.38, issue.5, pp.813-823, 2005.

U. Holzgrabe, R. Deubner, C. Schollmayer, and B. Waibel, Quantitative NMR spectroscopy?applications in drug analysis, J. Pharm. Biomed. Anal, vol.38, issue.5, pp.806-812, 2005.

J. A. Orwa, C. Govaeris, R. Busson, and E. Roets, Van Schepdael, A.; Hoogmartens, J. Isolation and structural characterization of colistin components, J. Antibiot, vol.54, issue.7, pp.595-599, 2001.

R. M. Shawar, D. L. Macleod, R. L. Garber, J. L. Burns, J. R. Stapp et al., Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Antimicrob Agents Ch, vol.43, issue.12, pp.2877-2880, 1999.

F. Walter, Q. Vicens, and E. Westhof, Aminoglycoside?RNA interactions, Curr. Opin. Chem. Biol, vol.3, issue.6, pp.694-704, 1999.

J. W. Costerton, K. Cheng, G. G. Geesey, T. I. Ladd, J. C. Nickel et al., Bacterial biofilms in nature and disease, Annu. Rev. Microbiol, vol.41, issue.1, pp.435-464, 1987.

D. Davies, Understanding biofilm resistance to antibacterial agents, Nat. Rev. Drug Discovery, vol.2, issue.2, pp.114-136, 2003.